| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 33.634 | 39.397 | 85.981 | 103.901 | 116.023 | 138.552 | 157.923 | 201.869 | 272.619 | 360.941 |
| Total Income - EUR | 33.634 | 39.419 | 87.544 | 105.373 | 116.515 | 138.689 | 162.644 | 202.948 | 285.312 | 363.782 |
| Total Expenses - EUR | 26.434 | 32.019 | 70.836 | 71.842 | 89.519 | 91.759 | 104.653 | 134.725 | 207.863 | 264.557 |
| Gross Profit/Loss - EUR | 7.200 | 7.400 | 16.708 | 33.530 | 26.996 | 46.930 | 57.991 | 68.223 | 77.449 | 99.225 |
| Net Profit/Loss - EUR | 6.210 | 7.021 | 15.653 | 32.484 | 25.831 | 45.582 | 56.469 | 66.365 | 74.777 | 88.589 |
| Employees | 1 | 3 | 8 | 7 | 7 | 8 | 6 | 10 | 13 | 13 |
Check the financial reports for the company - Sylmed Invest S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.335 | 1.941 | 18.497 | 13.142 | 10.625 | 23.907 | 24.794 | 18.046 | 15.844 | 41.319 |
| Current Assets | 10.655 | 17.708 | 24.524 | 56.544 | 79.159 | 61.539 | 122.799 | 152.245 | 117.386 | 94.543 |
| Inventories | 1.950 | 4.257 | 7.767 | 8.593 | 8.457 | 8.579 | 9.047 | 10.014 | 11.722 | 17.194 |
| Receivables | 5.093 | 6.323 | 14.891 | 14.069 | 17.691 | 11.227 | 18.224 | 22.667 | 102.185 | 68.290 |
| Cash | 3.612 | 7.128 | 1.866 | 33.882 | 53.011 | 41.733 | 95.528 | 119.564 | 3.479 | 9.059 |
| Shareholders Funds | 10.519 | 17.432 | 26.748 | 58.741 | 75.848 | 75.234 | 130.034 | 121.027 | 111.935 | 88.967 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.472 | 2.217 | 16.274 | 10.945 | 13.935 | 10.211 | 17.559 | 49.264 | 22.295 | 46.895 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Sylmed Invest S.r.l.